Press Releases
PharmaDiagnostics awarded European patent for label-free SoPRano ADME assays
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized instrumentation, announces today that it has been awarded a European patent for its innovative SoPRano ADME assays (absorption, distribution, metabolism, and...
Press Releases
CIT and Stemina Biomarker Discovery announce partnership in Europe for stem cell based toxicology testing
CIT – Safety and Health Research Laboratories and Stemina Biomarker Discovery, Inc. announced that CIT and Stemina have entered into a strategic partnership. Under the arrangement, CIT will distribute Stemina’s devTOX(TM) assay in Europe and will work with Stemina...
Press Releases
Personalized medicine: The partnership imperative
Cecilia Schott, business development director for personalized healthcare with AstraZeneca, on why partnerships between pharmaceutical and diagnostics companies are key to the success of personalized medicine. AstraZeneca realizes it cannot achieve its mission "to make the...
Press Releases
Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
Eli Lilly and Company announced that the Mirror Portfolio, a concept created by Lilly to access innovation being developed outside the company's walls, has achieved a significant milestone. One of the independent venture capital firms participating in the Mirror...
Press Releases
Gilead Sciences Refiles New Drug Application with the FDA for Single-Tablet Regimen of Truvada(R) and TMC278
Gilead Sciences, Inc. announced that it has refiled a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for the single-tablet regimen of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase...
Press Releases
Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement for Elan’s Antibody-Based Therapeutics Pipeline
Elan plc and Boehringer Ingelheim announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics. Under the terms of the agreement, Boehringer Ingelheim will perform the technical development, clinical manufacturing and all related...
Press Releases
Cancer Can Be Prevented-Latest cancer preventability data released to mark World Cancer Day
On World Cancer Day, new independent evidence confirms that the increasing global trend of unhealthy and sedentary lifestyles is responsible for putting millions at an unnecessarily high risk of cancer. New estimates released today by the World Cancer Research...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read